Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mood brighteners, affect tolerance, and the blues.

R S Schwartz1

  • 1Adult Outpatient Clinic, McLean Hospital, Belmont, MA 02178.

Psychiatry
|November 1, 1991
PubMed
Summary

Hypothetical mood-brightening medications could alleviate everyday low moods in non-depressed individuals. Further research is needed to explore the implications of such mood-enhancing drugs without adverse effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The experimental animal models for assessing treatment of restenosis.

Cardiovascular radiation medicine·2001
Same author

Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with 'healthy' subjects dying out of hospital.

Atherosclerosis·2001
Same author

Increased oxidative stress in experimental renovascular hypertension.

Hypertension (Dallas, Tex. : 1979)·2001
Same author

Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty.

Arteriosclerosis, thrombosis, and vascular biology·2001
Same author

Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity.

The Journal of nutrition·2001
Same author

Immunodeficiency, immunosuppression, and susceptibility to neoplasms.

Journal of the National Cancer Institute. Monographs·2001

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Medical Ethics

Background:

  • The concept of a hypothetical medication designed to "brighten" non-clinical low moods is introduced.
  • Current mood elevators may cause euphoria or side effects, highlighting a need for safer alternatives.
  • The potential for drugs to mitigate common experiences of drudgery is considered.

Purpose of the Study:

  • To explore the hypothetical concept of a mood-brightening medication for individuals not clinically depressed.
  • To consider the future development of drugs that improve mood without significant side effects or impairment.
  • To initiate discussion on the ethical and societal implications of such pharmacological interventions.

Main Methods:

  • Conceptual exploration and thought experiment based on a colleague's challenge.
  • Discussion of existing medications like fluoxetine as potential precursors.
  • Consideration of future pharmacological possibilities and their societal impact.

Main Results:

  • The idea of a mood brightener that targets episodic low moods without causing euphoria or abuse-related side effects is proposed.
  • Fluoxetine is identified as a potential step towards such medications.
  • The inevitability of drugs reducing common drudgery is suggested, even for those without diagnosed mood disorders.

Conclusions:

  • The development of mood-brightening medications for sub-clinical mood states is a plausible future direction.
  • Societal and ethical considerations surrounding mood-enhancing drugs should be addressed proactively.
  • Further dialogue is necessary to understand the implications of non-impairing mood-altering medications.

Related Experiment Videos